BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perry C, Rayat ACME. Lentiviral Vector Bioprocessing. Viruses 2021;13:268. [PMID: 33572347 DOI: 10.3390/v13020268] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Broussau S, Lytvyn V, Simoneau M, Guilbault C, Leclerc M, Nazemi-Moghaddam N, Coulombe N, Elahi SM, McComb S, Gilbert R. Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning. Mol Ther Methods Clin Dev 2023;29:40-57. [PMID: 36936448 DOI: 10.1016/j.omtm.2023.02.013] [Reference Citation Analysis]
2 Nikita S, Mishra S, Gupta K, Runkana V, Gomes J, Rathore AS. Advances in bioreactor control for production of biotherapeutic products. Biotechnol Bioeng 2023. [PMID: 36760086 DOI: 10.1002/bit.28346] [Reference Citation Analysis]
3 Moreira AS, Bezemer S, Faria TQ, Detmers F, Hermans P, Sierkstra L, Coroadinha AS, Peixoto C. Implementation of Novel Affinity Ligand for Lentiviral Vector Purification. Int J Mol Sci 2023;24. [PMID: 36834764 DOI: 10.3390/ijms24043354] [Reference Citation Analysis]
4 Jiang Z, Xu Y, Fu M, Zhu D, Li N, Yang G. Genetically modified cell spheroids for tissue engineering and regenerative medicine. J Control Release 2023;354:588-605. [PMID: 36657601 DOI: 10.1016/j.jconrel.2023.01.033] [Reference Citation Analysis]
5 Labisch JJ, Paul R, Wiese GP, Pflanz K. Scaling Up of Steric Exclusion Membrane Chromatography for Lentiviral Vector Purification. Membranes (Basel) 2023;13. [PMID: 36837652 DOI: 10.3390/membranes13020149] [Reference Citation Analysis]
6 Williams S, Jalal AR, Lewis MP, Davies OG. A survey to evaluate parameters governing the selection and application of extracellular vesicle isolation methods. J Tissue Eng 2023;14:20417314231155114. [PMID: 36911574 DOI: 10.1177/20417314231155114] [Reference Citation Analysis]
7 Syzdykova L, Zauatbayeva G, Keyer V, Ramanculov Y, Arsienko R, Shustov AV. Process for production of chimeric antigen receptor-transducing lentivirus particles using infection with replicon particles containing self-replicating RNAs. Biochemical Engineering Journal 2023. [DOI: 10.1016/j.bej.2023.108814] [Reference Citation Analysis]
8 Celebi Torabfam G, Yetisgin AA, Erdem C, Cayli A, Kutlu O, Cetinel S. A feasibility study of different commercially available serum-free mediums to enhance lentivirus and adeno-associated virus production in HEK 293 suspension cells. Cytotechnology 2022;74:635-55. [PMID: 36389283 DOI: 10.1007/s10616-022-00551-1] [Reference Citation Analysis]
9 Morizako N, Butlertanaka EP, Tanaka YL, Shibata H, Okabayashi T, Mekata H, Saito A. Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector. Sci Rep 2022;12:16952. [PMID: 36258028 DOI: 10.1038/s41598-022-20970-6] [Reference Citation Analysis]
10 Li R, Wang Q, She K, Lu F, Yang Y. CRISPR/Cas systems usher in a new era of disease treatment and diagnosis. Mol Biomed 2022;3:31. [PMID: 36239875 DOI: 10.1186/s43556-022-00095-y] [Reference Citation Analysis]
11 Wang X, He Z. Lentiviral Vectors for Gene Therapy. eLS 2022. [DOI: 10.1002/9780470015902.a0029449] [Reference Citation Analysis]
12 Munz CM, Kreher H, Erdbeer A, Richter S, Westphal D, Yi B, Behrendt R, Stanke N, Lindel F, Lindemann D. Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells. Mol Ther Methods Clin Dev 2022;26:394-412. [PMID: 36034773 DOI: 10.1016/j.omtm.2022.07.004] [Reference Citation Analysis]
13 Pang Z, Wang Z, Li F, Feng C, Mu X. Current Progress of CAR-NK Therapy in Cancer Treatment. Cancers (Basel) 2022;14:4318. [PMID: 36077853 DOI: 10.3390/cancers14174318] [Reference Citation Analysis]
14 Sharma P, Kumar A, Agarwal T, Dey AD, Moghaddam FD, Rahimmanesh I, Ghovvati M, Yousefiasl S, Borzacchiello A, Mohammadi A, Yella VR, Moradi O, Sharifi E. Nucleic acid-based therapeutics for dermal wound healing. Int J Biol Macromol 2022;220:920-33. [PMID: 35987365 DOI: 10.1016/j.ijbiomac.2022.08.099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Morizako N, Butlertanaka EP, Tanaka YL, Shibata H, Okabayashi T, Mekata H, Saito A. Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector.. [DOI: 10.21203/rs.3.rs-1913714/v1] [Reference Citation Analysis]
16 Takeuchi Y. Special Issue "Lentiviral Vectors". Viruses 2022;14:1492. [PMID: 35891475 DOI: 10.3390/v14071492] [Reference Citation Analysis]
17 Labisch JJ, Kassar M, Bollmann F, Valentic A, Hubbuch J, Pflanz K. Steric exclusion chromatography of lentiviral vectors using hydrophilic cellulose membranes. Journal of Chromatography A 2022;1674:463148. [DOI: 10.1016/j.chroma.2022.463148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wagner DL, Koehl U, Chmielewski M, Scheid C, Stripecke R. Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene Editing. Front Immunol 2022;13:865424. [DOI: 10.3389/fimmu.2022.865424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tran MY, Kamen AA. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing. Front Bioeng Biotechnol 2022;10:887716. [DOI: 10.3389/fbioe.2022.887716] [Reference Citation Analysis]
20 Jiang Z, Fu M, Zhu D, Wang X, Li N, Ren L, He J, Yang G. Genetically modified immunomodulatory cell-based biomaterials in tissue regeneration and engineering. Cytokine Growth Factor Rev 2022:S1359-6101(22)00039-9. [PMID: 35690567 DOI: 10.1016/j.cytogfr.2022.05.003] [Reference Citation Analysis]
21 Jabra MG, Zydney AL. Design and optimization of Single Pass Tangential Flow Filtration for inline concentration of monoclonal antibodies. Journal of Membrane Science 2022;643:120047. [DOI: 10.1016/j.memsci.2021.120047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Deng S, Qi M, Gong P, Tan Z. The circadian clock component BMAL1 regulates osteogenesis in osseointegration. Front Pediatr 2022;10:1091296. [PMID: 36619505 DOI: 10.3389/fped.2022.1091296] [Reference Citation Analysis]
23 Sarkis M, Tak K, Chachuat B, Shah N, Papathanasiou MM. Towards Resilience in Next-Generation Vaccines and Therapeutics Supply Chains. Computer Aided Chemical Engineering 2022. [DOI: 10.1016/b978-0-323-95879-0.50156-9] [Reference Citation Analysis]
24 Coroadinha AS. Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2441-8_16] [Reference Citation Analysis]
25 Roesch A, Zölls S, Stadler D, Helbig C, Wuchner K, Kersten G, Hawe A, Jiskoot W, Menzen T. Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells. J Pharm Sci 2021:S0022-3549(21)00689-4. [PMID: 34919969 DOI: 10.1016/j.xphs.2021.12.011] [Reference Citation Analysis]
26 Emerson J, Glassey J. Bioprocess monitoring and control: challenges in cell and gene therapy. Current Opinion in Chemical Engineering 2021;34:100722. [DOI: 10.1016/j.coche.2021.100722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Fowler D, Nattress C, Navarrete AS, Barisa M, Fisher J. Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment. Cancers (Basel) 2021;13:6000. [PMID: 34885108 DOI: 10.3390/cancers13236000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Singh SM, Furman R, Singh RK, Balakrishnan G, Chennamsetty N, Tao L, Li Z. Size exclusion chromatography for the characterization and quality control of biologics. Journal of Liquid Chromatography & Related Technologies 2021;44:265-78. [DOI: 10.1080/10826076.2021.1979582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Staubach S, Bauer FN, Tertel T, Börger V, Stambouli O, Salzig D, Giebel B. Scaled preparation of extracellular vesicles from conditioned media. Adv Drug Deliv Rev 2021;177:113940. [PMID: 34419502 DOI: 10.1016/j.addr.2021.113940] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
30 Minh AD, Kamen AA. Critical Assessment of Purification and Analytical Technologies for Enveloped Viral Vector and Vaccine Processing and Their Current Limitations in Resolving Co-Expressed Extracellular Vesicles. Vaccines (Basel) 2021;9:823. [PMID: 34451948 DOI: 10.3390/vaccines9080823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Bracewell DG, Smith V, Delahaye M, Smales CM. Analytics of host cell proteins (HCPs): lessons from biopharmaceutical mAb analysis for Gene therapy products. Curr Opin Biotechnol 2021;71:98-104. [PMID: 34311150 DOI: 10.1016/j.copbio.2021.06.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Labisch JJ, Wiese GP, Barnes K, Bollmann F, Pflanz K. Infectious titer determination of lentiviral vectors using a temporal immunological real-time imaging approach. PLoS One 2021;16:e0254739. [PMID: 34265014 DOI: 10.1371/journal.pone.0254739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Dong W, Song Z, Liu S, Yu P, Shen Z, Yang J, Yang D, Hu Q, Zhang H, Gu Y. Adipose-Derived Stem Cells Based on Electrospun Biomimetic Scaffold Mediated Endothelial Differentiation Facilitating Regeneration and Repair of Abdominal Wall Defects via HIF-1α/VEGF Pathway. Front Bioeng Biotechnol 2021;9:676409. [PMID: 34307320 DOI: 10.3389/fbioe.2021.676409] [Reference Citation Analysis]
34 Sarkis M, Bernardi A, Shah N, Papathanasiou MM. Decision support tools for next-generation vaccines and advanced therapy medicinal products: present and future. Current Opinion in Chemical Engineering 2021;32:100689. [DOI: 10.1016/j.coche.2021.100689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]